Santen

Santen, a Japanese biopharmaceutical company founded in 1890, has grown into a leading ophthalmic pharmaceutical company in the world.

Concentrating its managerial resources in the ophthalmic and rheumatic fields, Santen has been supplying epochal eye drops for a variety of eye diseases, including glaucoma and dry eye.

To offer products that meet the demands of medical professionals and patients, our staff engaged in research and development, and production and quality compliance develop their activities through solid partnerships with doctors, while our sales and marketing staff work to build such partnerships by providing their advanced knowledge and the latest information in the ophthalmic and rheumatic fields.

Our product pipeline includes major products for eyes care. Santen's product range covers the main eye diseases such as dry eye, allergic conjunctivitis, glaucoma, cataract, eye infection, age-related macular degeneration etc.


Cationorm®

Cationorm® is an innovative artificial tear with the Novasorb® emulsion technology. It is a cationic oil-in-water emulsion that has different functions such as:

• Improving the stability of the tear film
• Hydration of the ocular surface which  induces lowering of the salt concentration of tears
• Lubrication due to the oil component which will enhance the lipid layer
• Protects ocular surface.
• It acts on the three layers of the tear film.

Through this mechanism of action, Cationorm provides immediate relief and lasting eye comfort.

Cationorm® is compatible with contact lenses and is unpreserved available in both, a multi-dose container and in a convenient single-dose container.

The recommended dosage is from one to four drop (s) per day in each eye.

For more info, please visit: www.santen.com